| Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:cyad | nasdaq:cyad Shareholders | 13F-HR | 0001475597-22-000010 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | HRT FINANCIAL LP | 1475597 | CELYAD ONCOLOGY SA | ADR | 151205200 | 88 | 36800 | SH | DFND | 36800 | 0 | 0 | May 17th, 2022 01:51AM | May 17th, 2022 01:51AM | Celyad | ||||
| nasdaq:cyad | nasdaq:cyad Shareholders | 13F-HR | 0001085146-22-002161 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Fortress Investment Group LLC | 1380393 | CELYAD ONCOLOGY SA | ADR | 151205200 | 15774 | 6500000 | SH | DFND | 1, 2, 3, 4 | 6500000 | 0 | 0 | May 17th, 2022 01:44AM | May 17th, 2022 01:44AM | Celyad | |||
| nasdaq:cyad | nasdaq:cyad Shareholders | 13F-HR | 0000950123-22-006403 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | CITADEL ADVISORS LLC | 1423053 | CELYAD ONCOLOGY SA | ADR | 151205200 | 35 | 14598 | SH | DFND | 1 | 14598 | 0 | 0 | May 17th, 2022 01:39AM | May 17th, 2022 01:39AM | Celyad | |||
| nasdaq:cyad | nasdaq:cyad Shareholders | 13F-HR | 0000950123-22-005967 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | UBS Group AG | 1610520 | CELYAD ONCOLOGY SA | ADR | 151205200 | 9 | 3554 | SH | DFND | 40 | 0 | 3554 | 0 | May 17th, 2022 01:35AM | May 17th, 2022 01:35AM | Celyad | |||
| nasdaq:cyad | nasdaq:cyad Shareholders | 13F-HR | 0000950123-22-005967 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | UBS Group AG | 1610520 | CELYAD ONCOLOGY SA | ADR | 151205200 | 1 | 500 | SH | DFND | 1 | 0 | 0 | 500 | May 17th, 2022 01:35AM | May 17th, 2022 01:35AM | Celyad | |||
| nasdaq:cyad | nasdaq:cyad Shareholders | 13F-HR | 0000072971-22-000135 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | WELLS FARGO & COMPANY/MN | 72971 | CELYAD ONCOLOGY SA | ADR | 151205200 | 34 | 14120 | SH | DFND | 15 | 0 | 0 | 14120 | May 17th, 2022 01:24AM | May 17th, 2022 01:24AM | Celyad | |||
| nasdaq:cyad | nasdaq:cyad Shareholders | 13F-HR | 0000072971-22-000135 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | WELLS FARGO & COMPANY/MN | 72971 | CELYAD ONCOLOGY SA | ADR | 151205200 | 8 | 3500 | SH | DFND | 13 | 0 | 0 | 3500 | May 17th, 2022 01:24AM | May 17th, 2022 01:24AM | Celyad | |||
| nasdaq:cyad | nasdaq:cyad Shareholders | 13F-HR | 0000895421-22-000458 | Mar 31st, 2022 12:00AM | May 13th, 2022 12:00AM | May 13th, 2022 12:00AM | MORGAN STANLEY | 895421 | CELYAD ONCOLOGY SA | ADR | 151205200 | 49 | 20000 | SH | DFND | 04 | 20000 | 0 | 0 | May 14th, 2022 01:20AM | May 14th, 2022 01:20AM | Celyad | |||
| nasdaq:cyad | nasdaq:cyad Shareholders | 13F-HR | 0000752798-22-000008 | Mar 31st, 2022 12:00AM | May 9th, 2022 12:00AM | May 9th, 2022 12:00AM | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 752798 | CELYAD SA | ADR | 151205200 | 0 | 0 | SH | SOLE | 0 | 0 | 0 | May 10th, 2022 01:24AM | May 10th, 2022 01:24AM | Celyad | ||||
| nasdaq:cyad | nasdaq:cyad Shareholders | 13F-HR | 0000926171-22-000019 | Mar 31st, 2022 12:00AM | May 5th, 2022 12:00AM | May 5th, 2022 12:00AM | NATIONAL BANK OF CANADA /FI/ | 926171 | CELYAD ONCOLOGY SA | ADR | 151205200 | 8 | 3400 | SH | DFND | 1 | 0 | 3400 | 0 | May 7th, 2022 01:44AM | May 7th, 2022 01:44AM | Celyad |